Home > Journals > Indian Journal of Ancient Medicine and Yoga

Indian Journal of Ancient Medicine and Yoga

Submit your article Read this Journals View all journals
Full Text (PDF)
Original Article

Can Cow Urine Distillate be Used for Human Health Care? If so, What Would be the Pharmaceutical Manufacturing Standards?

Aman Kumar , Aman Kumar , S. Ananthnarayan Sharma , G. Paran Gowda , Sri Haridas , Acharya Balkrishna

Author Information

Licence:



Indian Journal of Ancient Medicine and Yoga 5(4):p 177-182, October - December 2012. | DOI:

How Cite This Article:

Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Cow Urine Distillate (CUD), is a modern pharmaceutical product with five US patents for use in cancer treatment and for other ailments. Many published papers in medical literature, including those in MEDLINE, document many therapeutic properties of CUD. Unfortunately, none of these papers have any information on minimum quality standards for CUD manufacturing: for use in pharmaceutical products for human health care. There also does not seem to exist any published paper discussing pharmaceutical quality standards for manufacturing CUD. Some possible pharmaceutical manufacturing quality standards have been suggested in this paper to start a discussion. 

 

Keywords: Cow urine distillate; CUD; Therapeutic properties of Cow Urine Distillate; Cow Urine Distillate utility in cancer treatment; Bio enhancement of antibiotics; Pharmaceutical manufacturing standards for Cow Urine Distillate. 

References

No records found.


About this article

Cite this article

Licence:



Received Accepted Published
N/A N/A N/A
DOI:

Keywords


Article Level Metrics

Last Updated

Monday 22 June 2026, 00:37:28 (IST)

1746

Accesses

2
492
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received N/A
Accepted N/A
Published N/A

licence




Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share